Ranieri, G.; Marech, I.; Niccoli Asabella, A.; Di Palo, A.; Porcelli, M.; Lavelli, V.; Rubini, G.; Ferrari, C.; Gadaleta, C.D.
Tyrosine-Kinase Inhibitors Therapies with Mainly Anti-Angiogenic Activity in Advanced Renal Cell Carcinoma: Value of PET/CT in Response Evaluation. Int. J. Mol. Sci. 2017, 18, 1937.
https://doi.org/10.3390/ijms18091937
AMA Style
Ranieri G, Marech I, Niccoli Asabella A, Di Palo A, Porcelli M, Lavelli V, Rubini G, Ferrari C, Gadaleta CD.
Tyrosine-Kinase Inhibitors Therapies with Mainly Anti-Angiogenic Activity in Advanced Renal Cell Carcinoma: Value of PET/CT in Response Evaluation. International Journal of Molecular Sciences. 2017; 18(9):1937.
https://doi.org/10.3390/ijms18091937
Chicago/Turabian Style
Ranieri, Girolamo, Ilaria Marech, Artor Niccoli Asabella, Alessandra Di Palo, Mariangela Porcelli, Valentina Lavelli, Giuseppe Rubini, Cristina Ferrari, and Cosmo Damiano Gadaleta.
2017. "Tyrosine-Kinase Inhibitors Therapies with Mainly Anti-Angiogenic Activity in Advanced Renal Cell Carcinoma: Value of PET/CT in Response Evaluation" International Journal of Molecular Sciences 18, no. 9: 1937.
https://doi.org/10.3390/ijms18091937
APA Style
Ranieri, G., Marech, I., Niccoli Asabella, A., Di Palo, A., Porcelli, M., Lavelli, V., Rubini, G., Ferrari, C., & Gadaleta, C. D.
(2017). Tyrosine-Kinase Inhibitors Therapies with Mainly Anti-Angiogenic Activity in Advanced Renal Cell Carcinoma: Value of PET/CT in Response Evaluation. International Journal of Molecular Sciences, 18(9), 1937.
https://doi.org/10.3390/ijms18091937
